MedTrace Logo

Incidence and Management of Driveline Infection in Patients with CH-VAD

NCT06878456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 181

Last updated 2025-03-17

No results posted yet for this study

Summary

The goal of this observational study is to learn about the incidence of the Driveline Infection of a novel full-magnetically levitated left ventricular assist device with a new design of driveline.

The main question it aims to answer is : The incidence of DLI in Chinese CH-VAD implanted advanced heart failure patients and the main risk factors.

CH-VAD has been approved in China for the treatment of patients with advanced heart failure.

Conditions

  • Driveline Infection

Sponsors & Collaborators

  • Wuhan Asia Heart Hospital

    collaborator OTHER

  • Sichuan Provincial People's Hospital

    collaborator OTHER

  • Zhejiang Provincial People's Hospital

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06878456 on ClinicalTrials.gov